NCT01080573View on ClinicalTrials.gov

Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

1,257

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Multiple Sclerosis
Trial Locations (1)

CM19 5GU

Bupa Home Healthcare, Harlow

All Listed Sponsors
lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT01080573 - Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis | Biotech Hunter | Biotech Hunter